1.Sclerosing agent injection in the treatment of benign thyroid cysts
Chinese Journal of Minimally Invasive Surgery 2001;0(03):-
Objective To investigate the feasibility of sclerosing agent injection in the treatment of benign thyroid cysts. Methods Clinical data of 60 patients with thyroid cysts, who had been treated by injection of absolute alcohol or 10% sodium chloride solution, were reviewed retrospectively. Results A total of 74 lesions existed in 60 patients, and 182 times of injection were performed, with a total cure rate of 98 3% (59/60). No complications occurred. Follow-up observations for 1~5 years (mean 2 years) found no recurrence. Conclusions Sclerosing agent injection is a feasible method for benign thyroid cysts, if an exclusion of cystic papillary carcinoma is made.
2.Transcranial magnetic stimulation-electroencephalography for diagnosis and evaluation in neuropsychiatric diseases
Nuo YANG ; Yingxuan LI ; Dongju YANG
Chinese Journal of Neuromedicine 2022;21(12):1261-1268
The simultaneous recording of transcranial magnetic stimulation electroencephalography (TMS-EEG) can measure the EEG signals of each brain region after receiving magnetic pulse stimulation with high time resolution. Combined with appropriate signal analysis technology, TMS-EEG has important research value in evaluating the excitability of each cortex, concussion activity and connection properties of brain regions. In recent years, the realization equipment and analysis methods of this technology have been rapidly developed, and the application fields have been gradually popularized. In this paper, the TMS-EEG technology and its application in diagnosis and evaluation of neuropsychiatric diseases are summarized as follows.
3.Epidemiological characteristics of fall mortality among the elderly in Taizhou
Liangyou WANG ; Lingchu LIU ; Dongju QIAO ; Yang LIU ; Siqi WANG ; Min HE ; Yuting SHA ; Xinwen REN ; Caihong HU ; Xiangfeng CONG
Journal of Preventive Medicine 2019;31(11):1105-1107
Objective:
To learn the epidemiological characteristics of fall mortality among the elderly people in Taizhou,and to provide basis for intervention strategies of fall in the elderly.
Methods:
Data of fall mortality among residents aged 60 years or over in Taizhou from 2016 to 2018,collected from Zhejiang Chronic Disease Surveillance Information Management System,was used for analysis of time,population and geographical characteristics of fall deaths. The epidemic trend of fall mortality in the elderly was described by annual percentage change(APC).
Results:
From 2016 to 2018,3 699 cases of fall death in Taizhou were reported,the crude and standardized mortality were 116.90/100 000 and 97.88/100 000. The standardized mortality of fall in women was 106.11/100 000,which was higher than 90.13/100 000 in men(P<0.05). The standardized mortality of fall in rural residents was 131.20/100 000,which was higher than 28.15/100 000 in urban residents(P<0.05). The mortality of fall in residents aged 65-69 years from 2016 to 2018 showed an upward trend(APC=4.20%,P<0.05),while the mortality trend of fall in other age groups was not statistically significant(P>0.05).
Conclusion
Fall was the first cause of injury death in the elderly aged 60 years or over in Taizhou. Females and rural residents have relatively higher fall mortality.
4.Ocular opsoclonus associated with anti-N-methyl-D-aspartate receptor encephalitis: a case report
Jing LIU ; Chunqiu FAN ; Aihua LIU ; Dongju YANG ; Fang CHEN ; Jian HAN
Chinese Journal of Neurology 2020;53(8):611-613
Ocular opsoclonus is a rare disorder of the saccadic system, in which fixation is continuously interrupted by involuntary, chaotic, rapid and multi-directional saccadic eye movements, interrupting the gaze-holding function, leading to“dancing eyes”. Ocular opsoclonus has rarely been reported in China. A case of ocular opsoclonus associated with anti-N-methyl-D-aspartate receptor encephalitis is reported to improve awareness about the ocular sign. The patient′s condition reached the peak at the 5th week. He developed ocular opsoclonus on the basis of nonconvulsive status epilepticus, accompanied by frequent involuntary movements of the mouth and limbs. The ocular opsoclonus gradually relieved on the 7th week with the active treatment.
5.Observation on the therapeutic effect of cryotherapy in the removal of granulation tissue under electronic bronchoscope
Cheng HE ; Dongju LIAO ; Yang LIU ; Qingfeng LIAO ; Yong JIAN
China Journal of Endoscopy 2024;30(7):1-8
Objective To explore and analyze the therapeutic effect of cryotherapy in the removal of granulation tissue under electronic bronchoscope,and find an efficient and safe auxiliary treatment technique for patients undergoing granulation tissue removal surgery.Method A clinical practice study was conducted on 41 patients who underwent granulation tissue removal surgery from June 2021 to June 2022.Patients were divided into groups using single and double numbers,with 21 patients assigned to single numbers included in the control group and 20 patients assigned to double numbers included in the observation group.Both groups underwent electronic bronchoscope granulation tissue removal surgery.During the surgery,the control group received argon-plasma coagulation(APC),while the observation group received cryotherapy.The levels of immune function indicators(including CD4+,CD8+and CD4+/CD8+),postoperative recovery related indicators,and effective rate of the two groups of patients were compared before and after treatment.Result Before treatment,there was no statistically significant difference in CD4+and CD4+/CD8+between the two groups of patients(P>0.05).After treatment,CD4+and CD4+/CD8+in the observation group were significantly higher than those in the control group,and the differences were statistically significant(P<0.05);Before treatment,there was no statistically significant difference in CD8+between the two groups of patients(P>0.05).After treatment,the observation group was significantly lower than the control group,and the difference was statistically significant(P<0.05);The effective rate of the observation group was 95.00%,higher than 80.95%of the control group.The postoperative pain visual analogue scale(VAS)of the observation group was(2.14±0.18)points,significantly lower than the control group's(6.09±0.95)points,and the differences were statistically significant(P<0.05);The first postoperative feeding time of the observation group was(6.08±0.76)hours,and the hospital stay was(5.12±0.68)days,which were shorter than the control group's(15.39±2.97)hours and(7.08±0.93)days;The treatment cost of the observation group was(10 500.60±80.70)yuan,which was lower than the control group's(19 800.00±126.00)yuan,and the differences were statistically significant(P<0.05);The incidence of postoperative complications in the observation group was 5.00%,lower than the control group's 23.81%,and the difference was statistically significant(P<0.05).Conclusion The application of cryotherapy in the removal of granulation tissue under electronic bronchoscope has a significant therapeutic effect.It can not only improve the surgical treatment effect of patients,improve their immune index levels,but also alleviate their postoperative pain,reduce the incidence of postoperative complications,and shorten their postoperative pre-and post cycle.Moreover,the treatment cost is low,and it is worthy of clinical application and promotion.
6.Effect of Guben Jiedu Prescription-medicated Serum on Epithelial-mesenchymal Transition of Lung Cancer A549 Cells: Based on PI3K/Akt Signaling Pathway
Dongju ZHU ; Bingkui PIAO ; Tengteng QIN ; Chen YANG ; Jianqi BAI ; Hongwei ZHU ; Ping ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(22):93-99
ObjectiveTo observe the effect of Guben Jiedu prescription (GBJ) on the epithelial-mesenchymal transition (EMT) of lung cancer A549 cells and to explore the mechanism based on phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. MethodThe GBJ-medicated serum was prepared. Cell viability was detected by methyl thiazolyl tetrazolium (MTT) assay to screen the optimal doses of GBJ-medicated serum for further experiment. A549 cells were classified into normal serum group, low-, medium-, and high-dose GBJ-medicated serum groups (2.5%, 5%, and 10% GBJ-medicated serum), PI3K/Akt pathway activator SC79 group, and high-dose GBJ-medicated serum + SC79 group. Cell migration ability was measured by wound-healing assay. The protein expression of E-cadherin, N-cadherin, vimentin, Akt, phosphorylated Akt (p-Akt), glycogen synthase kinase-3β (GSK-3β), and phosphorylated GSK-3β (p-GSK-3β) was detected by Western blotting, and the mRNA expression of N-cadherin and vimentin by Real-time PCR. ResultCompared with the normal serum, GBJ-medicated serum (2.5%, 5%, 10%, 20%, 40%) decreased the viability of A549 cells (P<0.05), and 10%, 5%, 2.5% GBJ-medicated serum was respectively selected for the follow-up experiment. The migration ability of cells in the high-, medium-, and low-dose GBJ-medicated serum groups was lower than that in the normal serum group. The expression of N-cadherin mRNA and Vimentin mRNA in A549 cells in the three GBJ-medicated serum groups was significantly lower than that in the normal serum group (P<0.01). The protein expression of E-cadherin was higher in the high- and medium-dose GBJ-medicated serum groups than in the normal serum group (P<0.01). The three GBJ-medicated serum groups showed lower protein expression of N-cadherin, vimentin, p-Akt, and p-GSK-3β (P<0.01) and lower expression of p-Akt/Akt, p-GSK-3β/GSK-3β (P<0.05, P<0.01) than normal serum group. Compared with the SC79 group, the high-dose GBJ-medicated serum group demonstrated high protein expression of E-cadherin (P<0.01) and low expression of N-cadherin, vimentin, p-Akt, p-GSK-3β, and p-Akt/Akt, p-GSK-3β/GSK-3β (P<0.01). Compared with the high-dose GBJ-medicated serum group, high-dose GBJ-medicated serum + SC79 group showed low protein expression of E-cadherin (P<0.01) and high protein expression of N-cadherin, vimentin, p-Akt, p-GSK-3β, p-Akt/Akt, and p-GSK-3β/GSK-3β (P<0.01). ConclusionGBJ can inhibit the migration and EMT of lung cancer A549 cells by regulating the PI3K/Akt signaling pathway.